|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/4523 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 27/00 | (2006.01) |
| (11) | Patento numeris | 3619208 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18724753.1 |
| Europos patento paraiškos padavimo data | 2018-04-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-03-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/030144 |
| Data | 2018-04-30 |
| (87) | Numeris | WO 2018/204236 |
| Data | 2018-11-08 |
| (30) | Numeris | Data | Šalis |
| 201762492571 P | 2017-05-01 | US |
| (72) |
DABROS, Marta , US
THALLADI, Venkat R. , US
NZEREM, Jerry , US
KLEINSCHEK, Melanie A. , US
CRATER, Glenn D. , US
|
| (73) |
Theravance Biopharma R&D IP, LLC ,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (54) | CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND |
| CRYSTALLINE FORMS OF A JAK INHIBITOR COMPOUND |